Protalix BioTherapeutics, Inc. (PLX)
NYSEAMERICAN: PLX · Real-Time Price · USD
3.030
-0.020 (-0.66%)
Nov 16, 2026, 4:00 PM EST - Market closed
Protalix BioTherapeutics Market Cap
Protalix BioTherapeutics has a market cap or net worth of $255.49 million as of November 16, 2026. It is the 18,858th most valuable company in the world and the 3,302nd biggest in the United States. Its market cap has increased by 70.78% in one year.
Market Cap
255.49M
Enterprise Value
216.09M
1-Year Change
70.78%
Global Rank
Country Rank
#3,302 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Protalix BioTherapeutics's market cap has increased from $11.80M to $255.49M, an increase of 2,065.14%. That is a compound annual growth rate of 11.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 16, 2026 | 255.49M | 76.44% |
| Dec 31, 2025 | 144.80M | 4.62% |
| Dec 31, 2024 | 138.40M | 6.54% |
| Dec 29, 2023 | 129.90M | 87.18% |
| Dec 30, 2022 | 69.40M | 83.11% |
| Dec 31, 2021 | 37.90M | -68.68% |
| Dec 31, 2020 | 121.00M | 148.46% |
| Dec 31, 2019 | 48.70M | 5.64% |
| Dec 31, 2018 | 46.10M | -50.11% |
| Dec 29, 2017 | 92.40M | 107.64% |
| Dec 30, 2016 | 44.50M | -56.29% |
| Dec 31, 2015 | 101.80M | -40.95% |
| Dec 31, 2014 | 172.40M | -52.64% |
| Dec 31, 2013 | 364.00M | -24.96% |
| Dec 31, 2012 | 485.10M | 14.93% |
| Dec 30, 2011 | 422.10M | -47.92% |
| Dec 31, 2010 | 810.50M | 58.46% |
| Dec 31, 2009 | 511.50M | 266.14% |
| Dec 31, 2008 | 139.70M | -45.71% |
| Dec 31, 2007 | 257.30M | 2,552.58% |
| Dec 29, 2006 | 9.70M | -21.77% |
| Dec 30, 2005 | 12.40M | 1,671.43% |
| Dec 31, 2004 | 700.00K | -41.67% |
| Dec 31, 2003 | 1.20M | 300.00% |
| Dec 31, 2002 | 300.00K | -57.14% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Turn Therapeutics | 268.43M |
| Lexeo Therapeutics | 263.36M |
| Ocugen | 260.99M |
| Clinuvel Pharmaceuticals | 259.42M |
| Cabaletta Bio | 256.71M |
| Inovio Pharmaceuticals | 255.99M |
| Arcturus Therapeutics Holdings | 254.79M |
| Q32 Bio | 254.65M |